Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 308 | 308 | 308 | 349 | 349 |
| Gross Profit | 308 | 308 | 308 | 349 | 349 |
| Operating Expenses | 3,667 | 4,188 | 4,475 | 4,010 | 4,113 |
| Operating Income | -3,359 | -3,881 | -4,168 | -3,661 | -3,764 |
| Other Income | 4 | 3 | 4 | 5 | 6 |
| Pre-tax Income | -3,355 | -3,878 | -4,163 | -3,656 | -3,759 |
| Net Income Continuous | -3,355 | -3,878 | -4,163 | -3,656 | -3,759 |
| Net Income | $-3,355 | $-3,878 | $-4,163 | $-3,656 | $-3,759 |
| EPS Basic Total Ops | -10.14 | -11.49 | -12.42 | -10.77 | 7.45 |
| EPS Basic Continuous Ops | -9.82 | -11.54 | -12.46 | -10.97 | 7.58 |
| EPS Diluted Total Ops | -10.14 | -11.49 | -12.42 | -10.77 | 7.45 |
| EPS Diluted Continuous Ops | -9.82 | -11.54 | -12.46 | -10.97 | 7.58 |
| EBITDA(a) | $-3,263 | $-3,783 | $-4,069 | $-3,565 | $-3,687 |